Tianjin Ringpu Bio-Technology Co.,Ltd. Share Price

Stocks

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote 25/08/2026 5-day change 1st Jan Change
17.48 CNY +0.81% Intraday chart for Tianjin Ringpu Bio-Technology Co.,Ltd. -7.22% -6.87%

Valuation : Tianjin Ringpu Bio-Technology Co.,Ltd.

Market Cap 7.81B 1.16B 997M 934M 855M 1.61B 111B 1.62B 11.06B 4.32B 55.93B 4.36B 4.27B 185B P/E 2026 *
17.9x
P/E 2027 * 15.7x
Enterprise Value 8.33B 1.24B 1.06B 996M 912M 1.72B 118B 1.72B 11.79B 4.61B 59.65B 4.65B 4.55B 197B EV / Sales 2026 *
2.22x
EV / Sales 2027 * 1.93x
Free-Float
51.96%
Yield 2026 *
1.74%
Yield 2027 * 2.81%
08-25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
06-09 Tianjin Ringpu Bio-Technology Co.,Ltd. signed an Equity Transfer Agreement to acquire an additional 30% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ringpai National Chain Veterinary Hospital Management Co., Ltd. for CNY 65.9 million. CI
04-27 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-29 Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026 CI
03-26 Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
11-28 Ringpu Bio-Technology Secures Registration For Feline Vaccine MT
29/10/25 Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd. CI
24/10/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25/08/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
14/07/25 Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit MT
13/06/25 Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. CI
30/04/25 Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. CI
1 day+0.81%
1 week-7.22%
Current month+2.70%
1 month+12.56%
3 months+7.44%
6 months-10.54%
Current year-6.87%
1 week 17.14
Extreme 17.14
19.59
1 month 15.43
Extreme 15.43
20.26
Current year 13.91
Extreme 13.91
21.51
1 year 13.91
Extreme 13.91
23.36
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
28.9
10 years 6.3
Extreme 6.3
44.41
Manager TitleAgeSince
Chief Executive Officer 53 29/03/2023
Director of Finance/CFO 51 27/04/2022
Corporate Officer/Principal 45 26/10/2020
Director TitleAgeSince
Chairman 63 11/05/2008
Director/Board Member 53 24/12/2019
Director/Board Member 51 09/01/2020
Date Insider Type Main position Quantity % Market Cap.
24/05/23 Buy 3,000 0.0009%
23/05/23 Buy 1,000 0.0003%
04/09/20 Sell

Chief Executive Officer

47,300 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
+0.81%-7.22%-25.55%+0.34% 1.16B
+1.76%0.00%-51.72%-58.97% 31B
+0.65%+3.95%+32.45%+106.67% 12.24B
+0.12%-3.23%-20.72%+4.23% 3.95B
+1.24%-1.51%-2.68%+18.48% 3.15B
+1.93%-5.94%+41.09%+37.42% 2.07B
+0.35%+0.85%+8.58%+20.26% 1.98B
+2.90%+3.33%+12.89%+142.66% 1.48B
+1.49%+0.29%-11.18%-40.04% 1.03B
-0.56%-0.14%-6.63%-22.12% 959M
Average +1.09%-0.13%-2.35%+20.89% 5.9B
Weighted average by Cap. +1.27%+0.57%-20.73%-3.08%

Financials

2026 *2027 *
Net sales 3.75B 558M 479M 448M 411M 774M 53.3B 776M 5.31B 2.08B 26.86B 2.1B 2.05B 88.9B 4.22B 628M 539M 504M 462M 870M 59.95B 873M 5.97B 2.34B 30.21B 2.36B 2.31B 100B
Net income 427M 63.49M 54.5M 51.02M 46.72M 88.01M 6.06B 88.26M 604M 236M 3.06B 238M 233M 10.11B 508M 75.55M 64.86M 60.72M 55.6M 105M 7.22B 105M 719M 281M 3.64B 284M 278M 12.04B
Net Debt 519M 77.27M 66.33M 62.1M 56.86M 107M 7.38B 107M 735M 287M 3.72B 290M 284M 12.31B 337M 50.14M 43.04M 40.29M 36.9M 69.5M 4.79B 69.7M 477M 187M 2.41B 188M 184M 7.99B
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,803
Date Price Change Volume
27/08/26 CN¥17.20 +2.08% 5,548,290
26/08/26 CN¥16.85 -3.60% 7,605,800
25/08/26 CN¥17.48 +0.81% 4,272,386
24/08/26 CN¥17.34 -3.24% 6,660,776
21/08/26 CN¥17.92 -3.71% 8,362,207
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
17.20CNY
Average target price
20.41CNY
Spread / Average Target
+18.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300119 Stock